8-K//Current report
Trillium Therapeutics Inc. 8-K
Accession 0001104659-21-130208
CIK 0001616212operating
Filed
Oct 26, 8:00 PM ET
Accepted
Oct 27, 6:00 AM ET
Size
230.5 KB
Accession
0001104659-21-130208
Documents
- 8-Ktm2130983d1_8k.htmPrimary
FORM 8-K
- EX-99.1tm2130983d1_ex99-1.htm
EXHIBIT 99.1
- EX-101.SCHtril-20211026.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABtril-20211026_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREtril-20211026_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLtm2130983d1_8k_htm.xml
IDEA: XBRL DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001104659-21-130208-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
Trillium Therapeutics Inc.
CIK 0001616212
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001616212
Filing Metadata
- Form type
- 8-K
- Filed
- Oct 26, 8:00 PM ET
- Accepted
- Oct 27, 6:00 AM ET
- Size
- 230.5 KB